No CrossRef data available.
Article contents
Early postnatal metabolic profile in neonates with critical CHDs
Published online by Cambridge University Press: 04 October 2022
Abstract
Background:
Cyanotic CHD is a life-threatening condition that presents with low oxygen saturation in the newborn period. Hypoxemia might cause alterations in the metabolic pathways. In the present study, we aimed to evaluate the early postnatal amino acid and carnitine/acylcarnitine profiles of newborn infants with cyanotic CHD.
Methods:
A single centre case-control study was conducted. Twenty-seven patients with cyanotic CHD and 54 healthy newborn controls were enrolled. As part of the neonatal screening programme, results of amino acid and carnitine/acylcarnitine were recorded and compared between groups.
Results:
Twenty-seven neonates with cyanotic CHD and 54 healthy newborns as controls were enrolled in the study. Cyanotic CHD neonates had higher levels of alanine, phenylalanine, leucine/isoleucine, citrulline, ornithine, C5, C5-OH; but lower levels of C3, C10, C12, C14, C14:1, C16, C16.1, C18, C5-DC, C6-DC, C16-OH, C16:1-OH when compared with the healthy controls.
Conclusion:
This study showed that there are differences between patients with cyanotic CHD and healthy controls in terms of postnatal amino acid and carnitine/acylcarnitine profiles.
- Type
- Original Article
- Information
- Copyright
- © The Author(s), 2022. Published by Cambridge University Press
References
Botto, LD. Epidemiology and prevention of congenital heart defects. In: Shaddy, RE, Penny, DJ, Feltes, TF, Cetta, F, Mital, S (eds). Moss and Adams Heart Disease in Infants, Children and Adolescents Including the Fetus and Yound Adult, 10th. Wolters Kluwer, 2022: 221–319.Google Scholar
Centers for Disease Control and Prevention (CDC). Racial differences by gestational age in neonatal deaths attributable to congenital heart defects---United States, 2003-2006. MMWR Morb Mortal Wkly Rep 2010; 59: 1208–1211.Google Scholar
East, CE, Colditz, PB, Begg, LM, Brennecke, SP. Update on intrapartum fetal pulse oximetry. Aust N Z J Obstet Gynaecol 2002; 42: 119–124.CrossRefGoogle ScholarPubMed
Verklan, MT, Padhye, NS, Turner, NC. Oxygen saturation levels in the first 30 minutes of life. Adv Neonatal Care 2008; 8: 231–236.CrossRefGoogle ScholarPubMed
Piquereau, J, Ventura-Clapier, R. Maturation of cardiac energy metabolism during perinatal development. Front Physiol 2018; 19; 9: 959.CrossRefGoogle Scholar
Imura, H, Caputo, M, Parry, A, Pawade, A, Angelini, GD, Suleiman, M-S. Age-dependent and hypoxia-related differences in myocardial protection during pediatric open-heart surgery. Circulation 2001; 103: 1551–1556.CrossRefGoogle ScholarPubMed
Julia, P, Kofsky, E, Buckberg, GD, Young, HH, Bugyi, H. Studies of myocardial protection in the immature heart. III. Models of ischemic and hypoxic/ischemic injury in the immature puppy heart. J Thorac Cardiovasc Surg 1991; 101: 14–22.CrossRefGoogle ScholarPubMed
Crass, MF III, Lombardini, JB. Release of tissue taurine from the oxygen-deficient perfused rat heart. Proc Soc Exp Biol Med 1978; 157: 486–488.CrossRefGoogle ScholarPubMed
Modi, P, Suleiman, MS, Reeves, BC, et al. Free amino acids in hearts of pediatric patients with congenital heart disease: the effects of cyanosis, age, and pathology. Ann Thorac Surg 2006; 81: 943–949.CrossRefGoogle ScholarPubMed
Stanley, WC, Recchia, FA, Lopaschuk, GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005; 85: 1093–1129.CrossRefGoogle ScholarPubMed
Huang, Y, Zhou, M, Sun, H, Wang, Y. Branched-chain amino acid metabolism in heart disease: an epiphenomenon or a real culprit? Cardiovasc Res 2011; 90: 220–223.CrossRefGoogle ScholarPubMed
Rohit, M, Rajan, P. Approach to cyanotic congenital heart disease in children. Indian J Pediatr 2020; 87: 372–380.CrossRefGoogle ScholarPubMed
Friedman, P, Yilmaz, A, Ugur, Z, et al. Urine metabolomic biomarkers for prediction of isolated fetal congenital heart defect. J Matern Fetal Neonatal Med 2021; 4: 1–8.Google Scholar
Beken, S, Abali, S, Yildirim Saral, N, et al. Early postnatal metabolic profile in neonates with different birth weight status: a pilot study. Pediatr Nephrol 2021; 36: 1923–1929.CrossRefGoogle Scholar
Dong, S, Wu, L, Duan, Y, et al. Metabolic profile of heart tissue in cyanotic congenital heart disease. Am J Transl Res 2021; 13: 4224–4232.Google ScholarPubMed
Yu, M, Sun, S, Yu, J, et al. Discovery and validation of potential serum biomarkers for pediatric patients with congenital heart diseases by metabolomics. J Proteome Res 2018; 17: 3517–3525.CrossRefGoogle ScholarPubMed
Drake, KJ, Sidorov, VY, McGulnness, OP, Wasserman, DH, Wikswo, JP. Amino acids as metabolic substrates during cardiac ischemia. Exp Biol Med 2012; 237: 1369–1378.CrossRefGoogle ScholarPubMed
Cheng, CW, Liu, MH, Tang, HY, Chen, ML, Wang, CH. Factors associated with elevated plasma phenylalanine in patients with heart failure. Amino Acids 2021; 53: 149–157.CrossRefGoogle ScholarPubMed
Holocek, M. Why are branched-chain amino acids increased in starvation and diabetes? Nutrients 2020; 12: 3087.CrossRefGoogle Scholar
D'antona, G, Ragnl, M, Cardile, A, et al. Banched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metab 2010; 12: 362–372.CrossRefGoogle ScholarPubMed
Navaei, AH, Shekerdemian, LS, Mohammad, MA, et al. Derangement of arginine and related amino acids in children undergoing surgery for congenital heart disease with cardiopulmonary bypass. Crit Care Explor 2020; 16: e0150. DOI 10.1097/CCE.0000000000000150.CrossRefGoogle Scholar
Molek, P, Zmudzki, P, Wlodarczyk, A, Nessler, J, Zalewski, J. The shifted balance of arginine metabolites in acute myocardial infarction patients. Sci Rep 2021; 11: 83. DOI 10.1038/s41598-020-80230-3.CrossRefGoogle ScholarPubMed
Evangeliou, A, Vlassopoulos, D. Carnitine metabolism and deficit--when supplementation is necessary? Curr Pharm Biotechnol 2003; 4: 211–219.CrossRefGoogle ScholarPubMed